INTRODUCTION
The number of animal diseases caused by retroviruses is already high, and it continues to increase as new agents are discovered [for example, feline immunodeficiency virus (60)] (see Table I ).
From this group we have selected the three diseases most important for their economic consequences. In a limited number of pages it is impossible to provide full details of any one disease, let alone three diseases. We have, therefore, selected the aspects presented below, giving preference to new knowledge necessary for understanding control measures; namely, the principal characteristics of the pathogen, epidemiology, diagnosis and prophylaxis. Symptoms and lesions are not described in full.
All retroviruses possess reverse transcriptase (a term incorporated in the name "retrovirus"), responsible for synthesising a copy of DNA from viral RNA.
The DNA thus formed (provirus) may be stored within the nucleus of certain host cells, and this original property explains the special features of the various retroviral infections. They are persistent infections, present throughout the life of the host animal and corresponding to the presence of "information" of viral origin integrated into the host's cells. In this integrated form the pathogen is sheltered from the immune defences of the host. With some exceptions, retroviruses are usually present within the infected animal in proviral form rather than in the form of complete virions in body fluids. For this reason, transmission usually takes place by transfer of blood or secretions containing infected cells, and it is favoured by all actions which permit the inoculation of even very small quantities of blood or other cell suspensions, such as arthropod bites, the absorption of colostrum, taking blood samples, giving mass injections and performing minor surgery.
Exceptional cases arise when there are mechanisms which permit mature virions to avoid defences of the body, such as an antigenic derivative, present particularly in equine infectious anaemia. This feature of persistent infection confers on retroviruses (as on herpesviruses) a guarantee of stability and the maintenance of infection within a herd or flock. Absence of spontaneous recovery from infection and persistence of the risk of transmission to healthy animals both require the application of appropriate control measures, the principles of which are well-known, but whose implementation may be prohibitively expensive.
The following account aims to present the essential current knowledge concerning these three retroviruses, with a view to controlling the diseases. The information is drawn from the references cited and from information supplied to the OIE by the countries listed in Table II. TABLE II aetiology of human neoplasms (including leukaemia) have proved negative (7). However, the virus can multiply in monkey cells and human cells (27) , and some workers have detected specific antibodies in chimpanzees inoculated with the virus (90).
TABLE III

Different forms of bovine leukoses (18)
From the economic aspect, EBL has never been a major cause of economic loss in infected herds. Its repercussions vary according to country. Only tumoral cases, inevitably fatal, produce direct economic loss. Their frequency depends on the rate of infection of animals; it therefore varies considerably from country to country, sometimes amounting to some hundreds of cases per 100,000 carcasses.
In some countries the rate of infection of herds is practically nil, while in others it may be over 50%.
Health requirements for importation of cattle into countries attempting to eradicate EBL have led every country involved in international trade in cattle to examine the epidemiological situation regarding EBL and to adopt a control policy which satisfies economic constraints.
VIROLOGY
The retrovirus of EBL is close to the human viruses HTLV I and HTLV II (39); its main characteristics have been reviewed recently (6).
The whole of its nucleotide sequence is now known, and this, taken with the general characteristics of retroviruses, makes it possible to identify special characteristics (65, 66, 67, 79) . Thus, there is a gene coding for protease which straddles the GAG and POL genes, but falls within a different scheme (Fig. 1) . Two small open-reading structures (SOR and LOR) are located close to the ENV gene. The product of LOR and SOR genes activates the transcription of viral messenger RNA (11, 30, 75, 76) and perhaps certain cellular mRNAs, which provides the basis for an explanation of the oncogenicity of this virus (6). Structural proteins of the virus include internal proteins (pl5, p24, pl2, pl4) and envelope glycoproteins (gp30 and the major glycoprotein gp51). Different epitopes of gp51 have been identified and are used in developing competitive ELISA techniques (62) capable of detecting antibodies to gp51 in infected cattle.
Lesionai forms Epidemiology EBL virus
Multicentric
At first the virus was replicated in cultures of spontaneously infected bovine lymphocytes from cattle with persistent lymphocytosis (50).
Virus may be produced, without cytopathic effect, in a continuous cell line of lymphocytes or by co-culture with infected lymphocytes in the presence of effector cells (bat cells, bovine embryonic spleen cells, fetal lamb kidney cells).
/) ü Infection with EBL virus is followed by the appearance of neutralising antibodies, incapable of averting the development of lymphosarcoma. Antibodies to gp51 injected into sheep protect them from virulent challenge infection (44).
To date, attempts to prepare an EBL vaccine (by concentration of gp51 antigen and adsorption to adjuvant, recombination with vaccinia virus, or incorporation into immunostimulant complexes) have given inconclusive results (55, 68), but there is hope of eventual success (6).
PATHOGENESIS
The pathogenesis of EBL is complex and remains obscure in a number of respects.
Infection with bovine leukaemogenic virus is manifested by three successive and cumulative states: inapparent infection, persistent lymphocytosis and lymphosarcoma.
Inapparent infection
The animal presents no clinical or haematological signs, and only the serological response is positive.
Infection may be acquired before birth (a small proportion being infected within the uterus). In an infected herd, the rate of infection increases with age.
After infection the delay before seroconversion varies from 2 to 8 weeks, and no doubt this depends to some extent on the amount of virus in the inoculum. The delay, therefore, is 3-4 weeks after inoculation of 5 million lymphocytes (equivalent to 1 ml of blood) by the intradermal, tracheal or subcutaneous routes. There is a similar delay after injection of 50 microlitres of blood. Nevertheless, under natural conditions the serological response of some cattle may not become positive to the immunodiffusion test until more than 3 months have elapsed.
Persistent lymphocytosis
There is a change in the blood picture of infected cattle to a persistent increase in lymphocytes. This persistent lymphocytosis seldom occurs before 2 years of age. In different herds it affects between 10% and 90% of the infected cattle.
It usually persists for many years, until the animal's death. Sometimes it precedes the appearance of tumours, the duration of evolution varying from a few weeks to a few years. It may also disappear before the appearance of tumours.
Persistent lymphocytosis is due to polyclonal proliferation of B-lymphocytes, characterised by the simultaneous presence of numerous lymphocytic clones, distinguishable by different zones of provirus integration in their chromosomes. They are not neoplastic cells because their ability to multiply in culture differs from that of transformed cells (6). By contrast, neoplastic cells are usually derived from a single cell clone and there are different zones of chromosomal provirus integration in the tumours (34). Finally, neoplastic cells integrate proviral DNA in their chromosomes, but synthesise little or no viral protein (6).
The increase in lymphocytes also involves T-lymphocytes (96). During persistent lymphocytosis, the antibody titre increases in parallel with the leukocyte count.
Lymphosarcoma
This is the only clinically manifest form, characterised by the appearance of tumours, associated with persistent lymphocytosis and a positive serological response.
Lymphosarcoma usually occurs in cattle aged 5-8 years. It develops in only a small proportion of infected cattle, amounting to 0.5%-1.0% of infected animals annually. The condition is rapidly fatal.
An immune response to EBL virus has no protective effect against tumour development. In an infected animal, the antibody titre is usually higher when lymphosarcoma develops than during persistent lymphocytosis alone.
There is no immunosuppression in animals with lymphosarcoma. Similarly, no immunosuppression has been found in animals infected within the uterus (81).
EPIDEMIOLOGY
Descriptive epidemiology
Infection with EBL virus has been encountered in most countries in which it has been sought and occurs in enzootic form in certain herds or regions.
The current situation differs considerably from country to country (Table IV) . Within a given country, the rate of infection in herds may vary considerably from region to region. In various countries the spread of infection is related to the importation of breeding animals.
The proportion of animals infected in a herd varies significantly, amounting to 30%-50% or more in some units.
In temperate countries, serological conversion of animals is more frequent at the end of summer (47); tumoral cases may occur at any time of the year.
Analytical epidemiology
Sources of virus
Practically the sole source of virus is infected cattle. EBL virus is present in the lymphocytes of infected animals; consequently, any material containing lymphocytes from an infected animal can be a source of infection.
a) Blood
Only the cellular fraction of blood contains the virus. However, after prolonged storage of blood samples (2 weeks at +4°C), the virus can be isolated from blood plasma, no doubt as a result of cell lysis (69). The degree of "viraemia" can be measured from the minimum amount of blood from an infected bovine capable of transmitting the disease: 1/l00th of a drop may suffice (57). Roberts et al. (74) showed that bovine blood can be infective two weeks before the appearance of serum antibodies. The infection is transmitted more readily by infected lymphocytes than by a suspension of viral particles (35).
b) Colostrum and milk
The virus has been detected in milk and colostrum from infected cows (33, 54). There is no information on whether this excretion is perennial during lactation, nor on its degree. Kinetic studies on the appearance of virus have shown that, for 15 days following inoculation of virus, it appears simultaneously in both milk and blood (89).
c) Semen
There have been many attempts to isolate EBL virus from semen in view of the risk of spread by AI bulls (3, 89, 41, 40) . Apparently, semen is not infective under normal conditions; however, in certain cases, traumatic or inflammatory lesions might facilitate infection through lymphocytes.
d) Other secretions and excretions
-Urine and faeces
Testing for virus by sheep inoculation has given negative results (52, 64).
-Saliva
Its virulence was demonstrated in 5 of 17 infected cattle (61). The virus has been isolated from the cellular fraction of bronchial lavage fluid from 6 of 9 infected cattle (72); in 2 of 6 cases the nasal secretion was infective (solely the non-cellular fraction). These results are not surprising in view of the permanent flow of lymphocytes between the general circulation and lung tissue. However, it remains possible that accidental contamination of samples with blood might have resulted in false positive results.
In summary, the presence of lymphocytes in a secretion or an excretion governs its infectivity. Extravasation of blood or a local inflammatory lesion may enhance the infectivity of a substance normally possessing little or no infectivity.
This may explain certain contradictory results concerning the infectivity of semen, saliva and urine from infected cattle. On the other hand, it seems probable that mastitis would increase the amount of virus in milk from infected cows.
It must be emphasised that blood, and particularly milk, are the most important infective materials under normal conditions.
Susceptibility
Susceptibility to infection must be distinguished from the expression of persistent lymphocytosis or the tumoral form.
-The intrinsic susceptibility of animals to infection is no doubt very similar. Various factors are involved:
The presence of colostral antibodies helps to protect the calves of infected cows (93, 36) .
Management conditions may play a decisive role in facilitating or preventing transmission depending on precautions taken in certain circumstances: dehorning, tattooing, minor surgery, mass blood sampling, etc. Opportunity for direct contact between animals also probably favours transmission (Lassauzet, personal communication, 1989) . This factor may explain the regular difference between the high infection rate of dairy herds and the lower rate of suckler herds, noted particularly in the USA, Canada, Australia and South Africa (see the reports from these countries).
Climatic conditions favourable to insect multiplication may favour transmission.
-Familial cases of persistent lymphocytosis have been amply recorded. In certain herds, the infection and its clinical manifestation are particularly prominent.
The ability to develop persistent lymphocytosis and even lymphosarcoma may be governed by genetic factors, although nothing is known of their nature or mode of action (38). Expectorated discharge from cattle is potentially infective and may play a role in transmission.
-Venereal route
Results of experiments have given contradictory results according to whether the inoculum deposited in the genital tract of cows consisted of lymphocytes from an infected bovine (when 4 of 6 cows became infected) (51), or a mixture of bull semen with infective lymphocytes (when 1 of 4 cows became infected) (71).
Thus, there seems to be an inactivating agent in semen which could explain the difficulty in isolating EBL virus from the semen of infected bulls.
The venereal route seems, therefore, to be of minor importance. However, no one has investigated the venereal transmission of EBL under natural conditions.
-Transmission within the uterus Transmission of the virus from dam to foetus is not now in doubt; only the rate of uterine infection within an infected herd varies from investigator to investigator.
The technique of investigation consists of serological testing of newborn calves before they have ingested colostrum (31). A more positive procedure is to recover virus from the lymphocytes of a newborn calf.
The rate of uterine transmission reported in the literature varies from a maximum of 14% to 25% of infected females in a herd known to be highly susceptible to the virus to just 3% to 6% of infected females in herds of average susceptibility (8). Transplacental transmission takes place during the final 6 months of intra-uterine life.
This mode of transmission is not negligible; only exceptionally, however, is it of more than minor importance in spreading the virus within a herd.
The transmissibility of infection by gametes to the ovum has been repeatedly denied; investigation of the transfer of 21 embryos 6-7 days after collection from 8 infected cows failed to detect a single infected calf (58). Observations of familial cases may be due to the influence of genetic factors and early infection.
b) Indirect transmission
This takes place through the infectivity of blood from infected animals.
-Transmission by arthropod bites
Epidemiological evidence has implicated arthropods in the transmission of EBL. In the USA and Japan, incidence of the infection is highest during the hot season when arthropods are most numerous (8). This observation has been confirmed in France (47).
In contrast to Tabanidae, mosquitoes play only a limited role in EBL transmission (10), for two reasons: their smallness and their feeding habit of usually beginning and ending a blood meal on the same host. This may be compared with identical findings in the case of equine infectious anaemia. More recently (24), the same authors achieved transmission with bites from 10 to 20 clegs. Just 0.1 µl of blood from a cow with persistent lymphocytosis was enough to transmit the infection. The number of lymphocytes required was about 1,500.
Finally, in addition to simple mechanical transmission, ticks can act as vectors of EBL through transstadial transmission (32).
To summarise, the vector role of arthropods, particularly tabanids, in the transmission of EBL is becoming increasingly certain (47).
-Iatrogenic transmission
The possibility of transmitting infective lymphocytes from bovine to bovine during blood sampling or by multiple injections with the same needle has long been suspected (95). The amount of residual blood within the lumen of an injection needle is sufficient to reproduce the infection (29). Certain veterinary practices of a prophylactic nature, involving syringes and needles (70) or even surgical instruments on an infected animal have been incriminated, even though the transmission of virus has not been proved experimentally (94).
The role of tattooing has been demonstrated clearly (59, 42, 37) .
In summary, one may echo the conclusions of Burridge and Thurmond (8) that: -About 5% of the calves born of infected cows will acquire infection within the uterus; -Transmission of virus by ingestion of colostrum or milk seems to be of limited importance; -Most cases become infected by contact with infected cattle by various means: promiscuity, insect bites or incautious veterinary interventions.
DIAGNOSIS AND DETECTION
We shall pass over the various laboratory procedures other than serological tests, because these are either standard techniques (histopathology) or are little used (e.g. haematological testing, following the introduction of serological and virological techniques). (See the report of Italy to the OIE, 1989.) EBL is detected solely by serological testing applied to samples of blood or milk (individual or mixed samples).
Principles
The delay between infection and seroconversion averages 2-8 weeks (53), but may extend beyond 3 months (20) . Antibodies persist in the serum throughout the economic life of the animal, but their titre fluctuates, particularly at the end of gestation and the start of lactation, when it falls considerably, often to below the detectable limit (49, 5).
Exceptional cases of calves born of infected cows and kept in strict isolation may not become positive for several months, even up to 3 years after the disappearance of antibodies of maternal origin (83). Such an occurrence is rare and must not detract from the basic concept that the maximum delay before antibodies become detectable is about 3 months.
In calves born of infected cows, the antibodies of maternal origin may not disappear until 3-7 months of age (2, 9, 21, 84, 58).
Techniques
The two most important techniques currently in use for serological detection of EBL are immunodiffusion in agar gel and ELISA.
Immunodiffusion in agar gel
This is the test used most widely. The technique has been standardised in certain countries (e.g. within the European Communities) and kits are available commercially. Instructions for standardising the reagents have been issued (see Appendix G of EC Directive 88/406 of 14th June 1988).
The test can be used only on blood serum (individual samples or small pooled samples). It is specific, sensitive and simple to perform; it has, however, to be read by a trained technician and is unsuitable for large-scale testing.
ELISA -enzyme-linked immunosorbent assay
This is being used to an increasing extent as a serological test for EBL (1, 4, 19, 26, 48, 63, 85, 86, 88, 45, 28, 25, 62) . Commercially available test kits provide various ELISA techniques (direct or competitive) and may utilise monoclonal antibodies (22).
ELISA may be applied to samples of serum or milk (individual or pooled). Uniformity has been introduced into the wide range of commercialised tests by means of a test protocol which provides for satisfactory levels of sensitivity and specificity (17). Within the European Communities, the minimum threshold value for antibody detection is similar to that required for the gel immunodiffusion test on serum, established by comparison with a reference serum (serum E4 at 1:10).
In the case of milk, a similar minimum level is required to give results at least as satisfactory as the immunodiffusion test performed on serum from the cow providing the milk sample.
This requirement is based on an assumption that the average titre of EBL antibodies is 25 times lower in milk than in serum from the same cow [derived from the 10 times figure arrived at by Florent et al. The ELISA test applied to an individual milk sample should reveal at least the quantity of antibodies in a 1:250 dilution of E4 serum (diluted 25 times more than the 1:10 dilution).
For pooled milk samples the same level of detectability is required, and this involves considering the number of cows which provided the sample or resorting to the whey concentration technique. The commercial ELISA kit examined by Forschner et al.
(25) was capable of detecting milk from one infected cow among milk from 100 cows.
Advantages of ELISA are its rapidity, the ease of testing a large number of samples at one session, objective reading and the possibility of automation. Systematic testing of batches from each producer should provide satisfactory sensitivity and specificity (17). Under these conditions, ELISA is economic and efficacious for systematic testing of dairy herds for the infection and for routine surveillance of freedom from the disease (15, 16).
Interpretation
Interpretation of serological results obtained with the serum from a given animal has to take into account the age of the animal, date of last contact with an infected animal and (in the case of young calves) the serological status of the dam. This is summarised in Table V .
TABLE V
Interpretation of serological results for individual diagnosis of EBL
At the individual level, every serologically positive bovine over 7 months of age should be considered as infected and, therefore, as a potential source of infection. No reliance can be placed on a negative result obtained at the end of gestation or the beginning of lactation in a cow of an infected herd.
The following rules apply at the herd level: a herd can be considered free from EBL only if two serological tests on all the animals over 7 months old, done 3 months apart, have been negative, provided that there has been no opportunity for infection during the interval.
PRECAUTIONS AGAINST INFECTION
EBL is an infectious disease caused by a virus which is transmitted mainly by contact of a healthy animal with an infected animal, so that it is possible to prevent the spread of the disease by taking appropriate precautions.
These measures are taken at the herd level, for protection or eradication, and also at regional and national levels. 
Control at herd level
Protection of a healthy herd a) Introduction of animals into the herd
The most obvious and effective measure is to avoid introducing an infected animal into the herd.
It is therefore necessary to test serum from a purchased animal while it is in quarantine; a single test should be adequate for animals from disease-free herds. By contrast, animals originating from an infected herd, or a herd of unknown EBL status, should be held in quarantine for 3 months and tested at the beginning and end of this period. It is difficult to arrange for such a long quarantine period in practice, so it is best to acquire only healthy animals for a herd free from EBL.
b) Veterinary interventions
The attention of veterinarians should be drawn to the absolute need to change the needle between herds when taking blood samples or making intravenous injections.
c) Grazing
Communal grazing of healthy and infected herds is a risk factor in regions where there are numerous tabanid flies or mosquitoes. By analogy with equine infectious anaemia, to limit the risk of arthropod transmission there should be a distance of about 50 metres between an infected and a healthy herd.
Periodic verification of the absence of infection from a herd is desirable. In the case of dairy herds, this can be done simply by ELISA, applied regularly to bulk milk from the herd.
For suckler herds, testing should be done annually on pooled serum samples collected for other purposes, such as brucellosis testing.
Eradication from infected herds
There are two types of measures to be implemented: -adoption of simple prophylactic rules to limit the spread of virus within the herd; -introduction of a control scheme which will lead to eradication.
a) Prophylactic rules -Injection needles and veterinary instruments
The prophylactic rules seek to avoid any transport of blood from one infected animal to another; it is therefore vital to use disposable needles for blood sampling and intravenous injections. Experimental findings are sufficiently convincing to place full responsibility on the veterinarian if this precaution is ignored.
Similarly, all surgical instruments used on many animals (as for dehorning and castration) must be disinfected, and another wise precaution is to use a fresh pair of plastic gloves for each rectal exploration. Pay special attention to controlling biting arthropods. There are ear tags which provide a repulsive effect for some months and it may be advisable to use them.
-Colostrum
Allowing a calf to suck colostrum from an infected dam does not present a major risk in comparison with the benefit to the calf in acquiring good passive immunity. Nevertheless, when possible pasteurise the colostrum, because this preserves immunoglobulin activity while destroying the virus (73, 77 ). An alternative is to feed colostrum from healthy cows.
b) Control scheme
There are two types of control schemes to eradicate the infection from an infected herd: elimination by slaughter of infected cattle or segregating infected cattle into separate buildings.
-Elimination of infected cattle
The following model is proposed: serological testing of all cattle over 7 months old, at intervals of 3 to 6 months; isolation and slaughter of seropositive animals. The herd is considered to be free from the disease when all animals which have lost their colostral antibodies are serologically negative on two occasions, 6 months apart.
This procedure has given excellent results. However, its efficacy is impaired by certain possible errors, such as: the lack of animal identification, substitution of animals, introduction of infected animals, taking serial blood samples with the same needle, etc. This is why it is necessary to achieve perfect coordination between the four categories involved: farmer, local veterinarian, diagnostic laboratory and State Veterinary Service (43).
On the other hand, the progress of control measures is slow when there is a high initial proportion of infected cattle or infected young.
The great difficulty of eradicating the disease from a heavily infected herd, wellknown in bovine brucellosis and bovine tuberculosis, justifies slaughter of the entire herd.
This type of prophylaxis has the advantage of being effective (80), easy to implement and applicable to all types of herds; but, in the absence of a subsidy policy for slaughter, it is far too expensive for the farmer since it involves the elimination of animals, only a few of which will have their value diminished by the tumoral form of the disease.
This prophylactic model is therefore difficult to apply by a farmer acting alone (at least in the case of heavily infected herds); it is, however, justified as part of collective action.
-Segregation of infected animals
The creation of a healthy herd from an infected herd has been tried successfully (82) by segregating healthy calves from the rest of the herd.
This type of prophylaxis requires adequate animal accommodation and strict management, and it provides the farmer with an incentive to eliminate EBL from his herd. In such a case it is necessary to employ very sensitive serological tests (or repeated testing) to avoid the introduction of an infected calf, in an early stage of seroconversion, into the healthy herd.
Control at regional or national levels
In general, eradication of a disease having a long incubation period, as do EBL and tuberculosis, can be accomplished only by taking into account all the infected animals, which are potential sources of infection over a long period, without restricting attention to the "tip of the iceberg" represented by actual outbreaks of the disease. This applies particularly to cases of EBL, in which most of the infected animals will complete their economic life without showing signs of the disease or even being suspected of infection.
Each country has to define its control policy in relation to the epidemiological situation and the objectives to be achieved.
In certain countries, because of the cost of such an infection-eradication programme, the objective may be confined to the export of breeding animals.
Eradication may be the objective in other countries, with a timetable for control and different stages established according to the epidemiological situation and the resources available. There is no universal programme. Each country has to define its own programme, taking into account the criteria stated above, in the light of experience gained by other countries which have reached the eradication stage.
The use of highly sensitive ELISA tests (possessing adequate specificity) on pooled samples of milk or blood has made early-stage detection of the infection economically feasible in most countries and has facilitated subsequent surveillance of healthy herds. Eradication from infected herds relies on individual testing.
The experience of those European countries which began control some years ago has shown that the application of conventional disease control measures overcomes the disease. Higher initial rate of infection in herds and incorrect implementation of control measures prolong eradication.
If the measures are applied correctly and the rate of infection is low, eradication is achieved rapidly.
The number of countries devoting considerable effort and resources to EBL control is increasing progressively. Such countries require observation of the rules, laid down in the OIE International Animal Health Code, which guarantee the absence of reinfection from imported cattle.
EQUINE INFECTIOUS ANAEMIA
Equine infectious anaemia (EIA) is a viral disease confined to equines, usually taking a chronic course, with acute episodes manifested by fever, anaemia, depression and oedematous swellings. This disease is characterised by persistent viraemia lasting for years, formation of lesions of immunological origin and antigenic variability of the causal virus.
Described for the first time in France in 1843 by Lignée, it was investigated during the second half of the 19th century by Vallée and Carré (143) ; this resulted in the isolation of the virus and definition of the modes of infection. Subsequently, EIA has been recognised in most countries and currently occurs with variable frequency and severity in numerous countries of America, Europe, Asia and Africa, as well as in Australia.
VIROLOGY
Little was known about EIA virus for a long time. This relative ignorance was due to the lack of a practical means of culturing in animals or in cells. The first cells known to permit multiplication of the virus, equine leukocytes, were difficult to culture (requiring a high concentration of serum in the culture medium, 50% or more, with frequent contamination by cytomegalovirus) and a satisfactory cell culture, a line of equine dermal cells, was not developed until later (121).
The general characteristics of EIA virus have been reviewed recently by Issel et al. (112) . It has the structure of a lentivirus and it buds from cytoplasmic membranes. Its reverse transcriptase is magnesium dependent.
The protein composition of the virus is now known. The RNA complex includes basic protein p11. Internal proteins are p9, pl5 (phosphorylated protein) and p26. The envelope is composed of glycoproteins gp90 and gp45 (107, 123, 124) . (See Fig. 2.) 
FIG. 2
Diagrammatic representation of EIA virus (107, 123, 124) The genetic organisation of EIA virus is similar to that of other retroviruses (Fig. 3) . Viral RNA is copied to DNA by reverse transcriptase. It is flanked by two terminal repeat regions (long terminal repeats) containing the signals for regulating gene expression. The gene GAG codes for the internal proteins and consists of 1,458 bases. Proteins are derived from a unique precursor polyprotein arranged in the following order: pl5-p26-pentapeptide-pll-p9.
FIG. 3 Genetic organisation of EIA virus (113)
The gene POL codes for reverse transcriptase. It is read in a different frame from that of the GAG gene and comprises 251 bases. Finally, the ENV gene (2,577 bases) codes for envelope glycoproteins. It does not cover the POL gene (114, 139, 131, 102, 127) . The viral genome also possesses three short reading frames named S1, S2 and S3, the first two of which are located in the region between the POL and ENV genes, while S3 is within the ENV gene (113, 139) . The product of S2 expression activates expression of the viral genome and acts on a target sequence situated between positions -31 and +22 in relation to the initiation site of transcription of viral messenger RNA (103).
The virus is propagated in cultures of macrophages from an infected horse or by infecting macrophage cultures from a healthy horse. It has a cytopathic effect on the cells, resulting in cell destruction. This procedure is difficult to use because it requires a source of macrophages and cytomegalovirus-free serum. A line of equine dermal cells also supports the replication of EIA virus without lesions being produced and may remain persistently infected during successive passages (121). Canine thymus cell line Cf2Th has similar properties (97).
Antigenic properties of the virus depend on many groups of antigens having different properties. Internal proteins p26 and pl5 induce the formation of antibodies detectable by complement fixation, immunofluorescence and particularly immunodiffusion in agar gel. These proteins are stable from one strain of virus to another and therefore constitute antigens suitable for diagnostic tests. However, p26 shares antigenic activity with the homologous protein of HIV virus and lentivirus of sheep and goats. Protein p15 is also antigenically homologous with p1 protein of HIV virus (122, 145). Envelope glycoproteins gp90 and gp45 participate in the neutralisation test. During the course of infection in a horse, Kono et al. (119) demonstrated that peripheral antigens of the virion give rise to antigenic variants to which the organism adapts by producing, after some delay, antibodies which neutralise the new specificity. This phenomenon makes it possible to understand the almost constant coexistence of virus and antibodies in the blood of an infected horse. The mechanisms of this antigenic derivative have been studied in detail; what follow are the principal results.
Experimental infection of a horse results in cyclic crises of hyperthermia. Viraemia is greatest during these crises and the virus is not usually detectable by inoculation of cell cultures between crises. There is a variable delay between peak viraemia and the synthesis of antibodies to a given variant. In general, there is no cross-neutralisation between different variants. The gp90 and/or gp45 of each variant present structural modifications, revealed by a different electrophoretic mobility. By contrast, there is no change in p26. Analysis of peptides and tryptic glycopeptides of each variant shows that the peptide maps of gp90 and gp45 differ for each variant, and the changes are not additive among variants appearing successively in the same horse. Glycopeptide maps of gp90 and gp45 show that there are two different types of glycosylation for each glycoprotein and that certain variants do not present the same map, although peptide maps for p26, pl5 and p9 are identical in all variants (132).
Epitope analysis of gp90 and gp45 in many consecutive isolates derived from the same initial strain was performed by Hussain et al. (106) using monoclonal antibodies. Two epitopes were conserved in all strains, recognised by non-neutralising monoclonal antibodies. Other epitopes were variable in expression (particularly those recognised by neutralising monoclonal antibodies). Practically all isolates differed on the criterion of epitope profile expressed. Isolates identical according to this criterion differed in their peptides and tryptic glycopeptides or their oligonucleotide maps. Certain neutralising epitopes in the original strain underwent slight alterations between variants, which made it impossible to neutralise the variant without upsetting fixation of the corresponding monoclonal antibody.
Information on modifications of the ENV gene and a study of their correlation with changes in antigenic structure has been provided recently by Payne et al. (128) . Subfragments of the ENV gene have been expressed as fusion protein in E. coli. Examination of these polypeptides by the "western blot" technique, using the monoclonal antibodies described above, has made it possible to localise approximately the sequences coding these epitopes. Some epitopes corresponding to non-neutralising antibodies are coded by constant regions and are maintained by different strains. Epitopes recognised by neutralising antibodies are seldom conserved and are coded by variable regions of the gene. Similar results have been obtained by using serum from horses infected experimentally or naturally. One epitope in the terminal COOH part of gp45 is recognised by all sera, while epitopes coded by the variable part of the protein give different responses according to the serum used. An epitope of the NH2 terminal part of gp90 is recognised only weakly. To summarise, the conserved (non-neutralising) epitopes are located in the NH2 part and terminal COOH of protein coded by the ENV gene. Variable (neutralising) epitopes are coded by the variable part of the ENV gene. Similar results have been described for HIV virus.
THE DISEASE
The incubation period lasts from 5 to 7 days to more than 3 months. The most typical form of the disease is a succession of crises of hyperthermia, during which viraemia reaches a peak. During these crises the animal presents intense fever, anorexia and anaemia which may be accompanied by other, inconstant signs (hepatorenal syndrome, gastro-intestinal syndrome, myocarditis, meningitis). These crises stop after about a year and the animal remains an asymptomatic carrier of the virus (99). The evolution may be acute, subacute or chronic. Inapparent forms may occur, either from the start or after manifestation of the clinical form. Macroscopic lesions are variable, depending on the clinical form, and include hepatomegaly, splenomegaly, myocarditis and haemorrhages (petechiae and suffusions) on serous and mucous membranes. Microscopic lesions consist of proliferation of lymphoid cells and infiltration of different organs (liver, spleen, etc.), with accumulation of sideroleukocytes (macrophages containing haemosiderin, a catabolite of haemoglobin).
PATHOGENESIS
Knowledge about the pathogenesis of EIA is steadily increasing.
-Anaemia results from two mechanisms: haemolysis, apparently of immunological origin, both intra-and extravascular, and impairment of bone marrow function.
Sentsui and Kono (133, 134) showed that haemolysis probably resulted from adherence of viral haemagglutinin to erythrocytes which are rapidly phagocytosed (sideroleukocytes) and then haemolysed through the action of complement. This haemolysis was quicker in the presence of antibodies directed against EIA virus.
-The glomerulitis of horses with acute EIA is accompanied by the presence of anti-EIA IgG and C3. This suggests that the lesion is due to deposition within the kidney of circulating virus-antibody complexes. McGuire et al. (120) found such circulating complexes and showed that 99% of infective virus in the serum was present in the complexes. Parallel with fixation of C3 to erythrocytes and glomeruli was a diminution in circulating C3 in the affected horses.
Mention was made in the section on virology that changes in the ENV gene are present in the antigenic variants which appear successively in an infected horse.
There are many hypotheses to account for the changes in sequence in the ENV gene. The most probable envisages the appearance of mutations during replication through a fault in the action of reverse transcriptase. Selection of new variants necessitates a functional immune response by the host (129), often explained by the presence of neutralising antibodies to existing variants. However, it is known that many cycles of fever and viraemia, associated with the isolation of different variants, occur before the appearance of neutralising antibodies. Early serum samples can distinguish these isolates by immunofluorescence of the membrane of infected cells. This suggests that the antigenic variation may result from recognition and destruction of infected cells by certain variants and not just by selection pressure from the existence of neutralising antibodies (118, 119, 98).
EPIDEMIOLOGY
Descriptive epidemiology
In many countries, the annual incidence of clinically expressed cases and the number of positive sera is falling. Table VI presents information provided by different countries. There are generally pronounced seasonal fluctuations in incidence, corresponding to the season of greatest arthropod activity. Spatial distribution of the disease varies from country to country. Often EIA is most common in hot, humid regions.
The disease shows no tendency to spread quickly, but some cases occur at a considerable distance from the initial outbreak.
Analytical epidemiology
The main sources of virus are infected horses. Sick horses are dangerous during crises of hyperthermia because their viraemia is at a peak, estimated to be 10 6 ID 50 per ml (110, 132). Between crises the virus titre is usually very low, but it can remain high in some horses. In horses with inapparent infection, without a history of manifest symptoms, the virus titre is usually very low and may even remain undetectable when 300 ml of blood is injected into a healthy horse (113). Certain secretions and excretions (milk, colostrum, nasal discharge) become infective during crises and may play a role in direct transmission (119). Injection needles or the bites of haematophagous arthropods are the habitual modes of EIA virus transmission through blood (the essential infective source). Existing knowledge about transmission of the virus by arthropods has been reviewed recently by Issel et al. (113) .
The arthropods involved belong to the genera Tabanus, Stomoxys, Chrysops and Hybomitra. Transmission is solely mechanical and EIA virus does not multiply within the arthropod (137). Various factors govern the efficacy of this transmission, particularly the status of the donor horse. Arthropod-borne transmission may succeed when a horse is in the acute stage of the disease (105). By contrast, experimental transmission from an afebrile horse, between crises, has failed on many occasions (116, 101), although transmission has been successful in some cases (116, 108) . Another important variable is the distance separating an infected horse from a healthy one. In fact, arthropods cannot act as vectors unless the blood meal on the infected horse The virus may also be transmitted by any material soiled with blood from an infected animal, such as injection needles and surgical equipment, because the virus can survive for several days on contaminated needles (144). Finally, uterine transmission is possible (115) but seems to be of limited epidemiological importance (111).
DIAGNOSIS
In the absence of virus isolation techniques suitable for routine use, diagnosis is based on the detection of antibodies which form after infection. (100), greatly helped the identification of infected horses. The antigen used was initially derived from extract of spleen obtained from a horse in the acute stage (126) and later from virus propagated in an equine dermal cell line (121). The major internal protein p26 is an essential constituent of the antigen. Its value has been confirmed by its antigenic stability between different strains of the virus (132). By contrast, although serum from infected horses reacts strongly with them, it is difficult to use envelope glycoproteins because of considerable antigenic variability (125, 128) . Nevertheless, an epitope of gp45 reacts strongly with serum from infected horses, and this property is present in various strains of virus (128), opening up new possibilities. Protein pl5 is another minor constituent of antigens used in immunodiffusion and may give a second precipitin line in Coggins test (142). ELISA techniques capable of detecting antibodies to p26 have been described (135, 138, 140) and some, capable of providing a result within 15 minutes, have been marketed. Finally, a variant of the "western blot" procedure has been developed (130).
Development of an agar gel immunodiffusion test, known as Coggins test
Coggins test is easy to perform, sensitive and specific. Even so, serum samples having a low antibody titre may yield results difficult to interpret. Some horses respond to infection with a low antibody titre (109, 141), although such cases account for less than 1% of all infected horses (113). This should not detract from the utility of Coggins test as an excellent diagnostic technique which enables nearly all infected horses to be detected with a remarkable specificity.
Execution of Coggins test is described in the OIE International Animal
Health Code (5th edition, pp. 323-327) and in the OIE Manual of recommended diagnostic techniques and requirements for biological products (Vol. I, 16). There is an international reference serum which represents the minimum level of detection to be achieved by a laboratory using Coggins test, defined as a result of a blind study by laboratories throughout the world of serum samples varying in antibody content.
Interpretation of Coggins test is based on the kinetics of formation of precipitating antibodies, which usually appear within 2 months of infection. They are usually present at the moment of appearance of symptoms but may not appear until later (up to 10 days after the onset of symptoms). Finally, serological testing may fail in foals born of seropositive mares because of the persistence of colostral antibodies, which are eliminated by 6 months of age. Interpretation of results of Coggins test is summarised in Table VII .
TABLE VII
Interpretation of testing for EIA antibodies
In a sick horse, a sideroleukocyte count may have prognostic value. The count is less than 7 per 100,000 leukocytes in a healthy horse, while during the days which follow an EIA crisis the count may reach 1,000 per 100,000 leukocytes. Protection of a country depends on checks on imported horses, which must have undergone recent serological testing and have come from stables where no case of EIA had occurred in the preceding 3 months (OIE International Animal Health Code, 5th edition, pp 202-203).
Animal Characteristics
To protect disease-free premises, it is necessary to check horses introduced. It is permissible to introduce seronegative horses originating from premises where all other horses are seronegative. If the status of the stable of origin is unknown, a horse should not be introduced unless it is seronegative, provided it is kept in quarantine for 45 to 60 days (the maximum time required for serological conversion) and has a negative test at the end of this period.
Eradication from infected stables requires the segregation of sick horses until they can be disposed of. Horses with inapparent infection can be detected by serological testing and then segregated pending disposal. Serological testing should be repeated at intervals of 30 to 45 days, applying the same procedure for positive horses. Serological testing may cease when two tests carried out 60 days apart have been negative in all horses. The foals of infected mares should be regarded as infected until a test performed 2 months after weaning has given a negative result. Care must be taken to use only disposable syringes and disposable needles and to carry out disinfection and insect control. Countries which have applied these measures rigorously have achieved a very significant reduction in the level of infection in their stables.
No vaccine of proven efficacy is currently available. Kono et al. (117) found that the use of an attenuated strain conferred protection against challenge infection with the homologous strain of virus, but not against a heterologous strain. A live vaccine is being used in China with apparently favourable results (136).
In conclusion, the measures for controlling EIA are well-established. Their effectiveness depends on the rigour with which they are applied, at least in countries where the level of infection is sufficiently low to permit the slaughter of infected horses.
CAPRINE ARTHRITIS-ENCEPHALITIS
Caprine arthritis-encephalitis (CAE) is a disease which has existed for many years, but it has not been investigated thoroughly until recently (see "History"). Cosmopolitan and caused by a virus similar to human AIDS virus, the disease is important not only in goat-keeping but also in comparative pathology.
This explains the large number of publications about the disease; in this brief review we shall not attempt to cover all of them. The emphasis will be on its geographical distribution and importance, drawing on reports submitted by different countries (Table VIII) . We shall also deal with aspects important for an understanding of control of the disease (virology, pathogenesis, epidemiology, control measures). 
DEFINITION AND NOSOLOGY
Clinical manifestations of the disease are as follows:
-In adult goats: symmetrical arthritis and periarthritis (most often affecting the carpal joints, but also the stifle joints and, more rarely, the hock and other joints). There is inflammation of serous bursae (particularly the atlanto-occipital and supraspinal bursae) and often udder sclerosis, producing an asymmetrical udder. In primiparous females, rapid development of diffuse induration of the udder ("wooden udder") just after parturition is regarded by some authors as a manifestation of CAE.
-In kids aged 2-6 months: posterior ataxia leading to rapidly fatal quadriplegia (leukoencephalomyelitis). There are also rare forms, such as a pulmonary form in young and adult goats and a nervous form in adults, which may or may not occur with the common forms (see "Diagnosis").
These various clinical forms belong to the same group, and at least the articular and nervous forms can be reproduced by inoculating susceptible goats with a retrovirus referred to as caprine arthritis-encephalitis virus (CAE). In the target organs there is intense infiltration by mononuclear cells (lymphocytes, monocytes and macrophages).
CAE is one of the slow virus diseases (207), along with other lentiviral diseases, such as ovine maedi-visna (161, 197) .
Infection of goats with CAE virus does not invariably produce a disease with symptoms and lesions, even though the infection persists throughout the life of the animal. Infection occurs most often during the first few months of life, leading to seroconversion against CAE virus within a few weeks. A certain proportion of infected animals (between 5% and 75% according to the herd) will develop clinical illness after a long incubation period (between 1 and 6-7 years), manifested by the signs described above for adults. These signs persist throughout the life of the animal, leading to deterioration in general health coupled with a diminution in production which justifies culling. The nervous form is much rarer in young animals than in adults; it is usually confined to heavily infected herds (those with more than 90% of adults seropositive).
The high prevalence of the infection in many countries and its consequences for the productivity of herds (particularly milk production), together with the obstacle it raises for trade in breeding animals, have given rise to numerous studies on its control. In certain countries, control is organised by governmental authorities and organisations of goat breeders.
HISTORY
The presence of "big knees", sometimes associated with lameness and deterioration of general health in adult goats, has been reported for some time by veterinarians and breeders. Contributions from Switzerland (210) and Japan (189) have described conditions very similar to the articular form of CAE in adults.
In 1974, without referring to previous observations, Linda Cork described an infectious leukoencephalomyelitis (ILE) of kids in the USA (159); because ILE was identified rapidly in other countries (180, 151) , the Cork description rekindled the interest of the scientific community. The same team (160) identified the virus responsible for ILE and proved that it was also responsible for chronic polyarthritis in adult goats similar to that described in Switzerland and Japan. Numerous publications (204) finally proved the existence of CAE virus infection and the presence of CAE in many countries.
VIROLOGY
CAE virus belongs to the subfamily Lentivirinae of Retroviridae.
It possesses certain properties in common with other lentiviruses, particularly with maedi-visna virus (192).
-Its genome consists of polyadenylated RNA of positive polarity, containing 9,000-10,000 pairs of bases for a molecular weight of 5.5 million daltons.
-The three structural genes GAG, POL and ENV code respectively for internal proteins of low mol. wt. (p28, pl9, pl6 and pl4), reverse transcriptase and 4 envelope glycoproteins, including gpl35.
-Antigenic variability in envelope glycoproteins occurs in field strains, as shown by neutralisation testing with antibodies directed against the glycoproteins (191). The spontaneous appearance of variants during the course of infection in a goat has been reported (168).
CAE virus and maedi-visna virus can be differentiated by means of genomic nucleotide sequences (202, 201) . The homology of these sequences between the two viruses is about 15% to 30% (171) under very specific conditions of hybridisation, and higher under less specific conditions (201).
-CAE virus replicates poorly in cells of ovine origin, without a pronounced cytopathic effect but with preference for synovial tissues. By contrast, maedi-visna virus lyses cells of ovine and caprine origin (192).
-It has not proved possible to demonstrate differences between strains of CAE virus derived from the arthritic and pneumonic forms of the disease by analysis of structural proteins, antigenic properties and behaviour in cell culture (169).
In the extracellular part of a culture, complete viral particles measure 80-100 nm; they have an electron-dense nucleus and form a homogeneous band upon isopycnic ultracentrifugation in sucrose at 1.15 g/cm 2 (156).
The virus can usually be isolated from expiants of synovial membrane of an affected joint (160, 193, 205) and also from other tissues (choroid plexus, lung, udder, leukocytes) of affected animals (163, 157). After one to five passages, the virus exerts a cytopathic effect manifested by syncytia formation, within which electron microscopy reveals dense nuclei and protrusion of virions at the surface of the cytoplasmic membrane. The virus can be passaged serially in primary cell cultures (synovial membrane, choroid plexus, kidney, thymus) from newborn kids which have not ingested colostrum (190).
The virus is relatively fragile in the environment and is completely inactivated by heating biological fluids (milk and colostrum) at 56°C for an hour (147).
PATHOGENESIS
The essential feature is persistence of subclinical infection for a long period (many years in adults, several months in kids). The virus usually enters the body from the digestive tract, reaching target cells of the monocyte-macrophage line (161, 192) .
In most cells, replication of the virus does not proceed beyond the provirus stage, which becomes closely associated with cellular DNA. This restriction involves the stage of transcription of messenger RNA.
In this "Trojan horse" form the virus is disseminated throughout the body by monocytes (174).
Neutralising antibodies are absent or present at only a low titre and do not participate in controlling virus replication. CAE virus can be recovered from the central nervous system, synovial membranes and also lymph nodes, udder and lung. Tissue lesions arise as a result of viral replication, associated with the transformation of monocytes and macrophages. There is at least partial immunological mediation in lesion development because, in goats immunised with inactivated CAE virus and then infected with a field strain of virus, the lesions develop rapidly and are more severe than those of non-immunised, infected goats (184). Similarly, De Martini et al. (164) showed that goats infected with CAE virus possess T-lymphocytes which are more responsive to mitogens than those from uninfected goats.
No doubt it will be demonstrated that genetic factors peculiar to goats can modulate the development of these lesions because this does occur with other lentiviruses (161). The influence of certain environmental factors (187) and intercurrent diseases (209) has been demonstrated. CAE virus differs from other lentiviruses by not inducing the formation of neutralising antibodies. This may be due to the mode of glycosylation of envelope glycoprotein, which might diminish the avidity of antibodies or impair antigenic determinants. On the other hand, it does induce antibodies to internal proteins, particularly protein p28.
Kids which show early clinical signs might have been infected within the uterus and then exposed to the virus in colostrum or milk (192) .
EPIDEMIOLOGY
Descriptive epidemiology
Distribution of the infection
The infection seems to be distributed widely in developed countries (149) (Table VIII) , particularly in North America (the USA and Canada) and in Europe. The infection rate is low in France (187), Norway, Switzerland and the United Kingdom (162). It seems to be widespread in Italy and in certain regions of Spain (172). By contrast, the Irish Republic and Northern Ireland seem to be free from the disease (146). In Africa, South Africa, Somalia and Sudan also seem to be free from the disease, while its prevalence is very low in Kenya (149) and essentially confined to female and male goats imported for breed improvement (148). Between nil and 18% of goats in Nigeria have been diagnosed as seropositive, depending on the region (153).
In Australia, the infection is widespread in dairy herds but much rarer in the Angora, Cashmere and Cashgora breeds (155, 173) ; it is absent from goats which have become feral (211, 166).
Serological prevalence is low in New Zealand (16% of goats and 1.5% of dairy herds according to MacDiarmid) (182) and is associated with imports; the situation is similar in the Fiji Islands (149).
In Latin America (Peru and Mexico), serological prevalence is low and infection is associated with imports, as in Haiti (149). In general, the dairy goat herds of North America, Europe and Australia are those which have introduced breeding goats from the countries which are apparently the most infected ones. Goats bred for their hair, and those of Latin America and Africa, seem to be little infected.
Distribution of the disease
Leukoencephalomyelitis of kids has been described in only a few countries and its incidence is low in the infected herds. It has been observed in the USA, Australia and Canada (204), as well as in Switzerland (170) and France (154, 198) , where its incidence appears to be very low (about 5% of the age group); it is mostly confined to heavily infected herds.
The adult polyarthritic form is encountered in every country where the leukoencephalomyelitic form occurs, but also in countries or herds of moderate serological prevalence (163, 154, 186) where the juvenile form does not occur. It is the most common clinical form of CAE.
The incidence of other clinical forms (nervous, pulmonary and mammary in adult goats) is more difficult to estimate (cf. "Diagnosis").
Analytical epidemiology
Under natural conditions, transmission of infection is mainly horizontal from dam to kid by colostrum and milk (147, 167) . This mode of transmission is favoured by the administration of pooled colostrum in intensively managed dairy herds, which explains the lower incidence of infection in herds which do not follow this procedure (traditional and Angora herds) (204).
Colostral antibodies, absorbed by the kid during the first 3 days of life, do not protect the kid and do not interfere with active antibody formation, nor with the development of CAE virus infection.
Kids born of infected dams and deprived of colostrum may still become infected (though to a much lesser extent) if they are kept in contact with the dam for a few hours after birth (through contact with genital secretions or through the digestive and respiratory routes) (see Table IX ).
Horizontal transmission between adults is possible, but it requires prolonged and close contact. In a small proportion of animals it can occur within two months (204), but in half of the cases 11-14 months are required (147, 204) .
Spread seems to occur most rapidly in dairy herds, for in one experiment (147) 60% of animals at risk became infected within 10 months. This result suggests a role for milking in transmission, supported by an epidemiological survey of dairy herds by Monicat (187).
Mating of uninfected females by an infected male does not seem to be important, and there is no evidence of aerosol transmission (147). In contrast to other retroviral infections (enzootic bovine leukosis and human AIDS), blood does not seem to be an effective means of transmission. Vertical transmission in the strict sense, within the uterus, seems to be very rare though not impossible (147), since lesions identical to those seen in other target tissues have been identified in the uterus of infected females (152); this type of transmission can occur occasionally in sheep with maedi. This could explain the appearance of the leukoencephalomyelitic syndrome in heavily infected herds having many clinical cases of the disease. However, its impact seems to be very limited in the development of the infection in production herds.
The question of infection of sheep by infected and/or affected goats is important for countries like New Zealand and Australia where maedi occurs among the sheep (which is also the case in the Irish Republic and Northern Ireland), and for every other country where the two species may be kept together. Experimental inoculation of CAE virus into lambs (intrathoracic route) gave negative results after an observation period of 16 weeks (208), though infection without illness has been produced by simultaneous intravenous, intracerebral and intra-articular inoculation (194) . Lambs fed for 3 months with milk from goats infected with CAE virus showed (in 4 of 6 cases) seroconversion to CAE virus, without clinical signs, during 13 months of observation (195) . Close contact for 8 months between infected goats and ewes did not infect the ewes (195). Smith et al. (209) demonstrated that Merino lambs in contact with infected goats for more than 24 months developed neither seroconversion nor lesions. On the other hand, 9 of 12 Merino lambs inoculated with CAE virus into the thorax became seropositive after 14-30 weeks. They were kept under observation for 67 to 142 weeks (over 31 months), but none became ill or developed lesions, although 7 of them had detectable viraemia. Two viraemic lambs were kept under observation for a further period of 140 weeks without any clinical sign of macroscopic or microscopic lesions developing (166).
It may be concluded that CAE virus is not pathogenic for the lines of sheep used in the Australian experiments, that infection of sheep by close contact with goats is impossible under normal conditions, and that for a lamb to become infected it must drink goat's milk for three months, something which does not occur in practice.
Efficacy of infection at birth of kids born of infected dams, in relation to husbandry system (147)
These conclusions, derived from animal experiments, are supported by in vitro findings (see the virology chapter).
DIAGNOSIS
This chapter will be confined to a succinct analysis and full details can be obtained from the references cited.
Virus infection
The usual test is immunodiffusion in agar gel for antibodies against glycoprotein 135 or protein 28, though ELISA techniques are also available (204, 212, 150, 206) .
In Europe, the antigen used for immunodiffusion is usually prepared from maedi-visna virus because of the close antigenic relationship between the two viruses (163, 199, 172 ). An ELISA using CAE virus antigen has been proposed by Houwers (163, 212) .
In the USA, Australia and New Zealand the antigens are prepared from CAE virus, whatever the test technique.
ELISA seems to be more specific, but less sensitive, than immunodiffusion (206).
Clinical disease
Diagnostic procedure is well-established (162), including differential diagnosis, for leukoencephalomyelitis in kids (158) and adult polyarthritis (180, 204, 172, 200) . Clinical indexes have been proposed as objective measurements of articular involvement (179, 164, 188) .
It is more difficult to diagnose the adult nervous forms and the very rare pulmonary forms (204), particularly when articular lesions are absent (203, 196) . Finally, the udder seems to be a target organ for replication of CAE virus (213, 178, 181) , but one cannot attribute with certainty udder abnormalities (asymmetry and hard udder) to CAE virus (204). In fact, while this type of abnormality is often associated with CAE virus infection or the development of other clinical forms of CAE, and this association has been confirmed (200, 187) , there is no good explanation for the association, nor has it been reproduced experimentally. Studies of maedi-visna in sheep have provided some diagnostic elements (165, 177) . Further studies of this aspect of CAE are needed because its economic impact can be considerable.
There is evidence of a relationship between the clinical index of the severity of CAE and the loss of milk production (187), and it would be interesting to distinguish loss arising from difficulty in moving about and loss resulting from mammary involvement.
If the disease is suspected in a herd, one looks for articular and synovial deformities among the adult goats (over one year old) and the existence of other possible manifestations, particularly the nervous form in kids. Confirmation of suspected occurrence depends on excluding other causes of adult polyarthritis (mycoplasmosis, chlamydiosis), on finding macroscopic and microscopic lesions, and on the degree of prevalence in the herd. The higher the latter, the more frequent the clinically expressed forms (186, 187, 199) . In most herds, when clinical disease affects a significant proportion of animals (more than 5%), between 50% and 100% of goats will be infected (187). It must be stressed that, as in the case of maedi, a considerable proportion of clinically affected animals will be seronegative [25% to 35% (212); 58% (173)]. There are some reports of an increase in the rate of infection with age (187) and other reports which failed to find this (173). There are also reports of a fall in serum antibody titre at peak lactation and when articular lesions appear (212).
PROPHYLAXIS
This chapter will deal with the principles of control; the reader will find details of individual schemes in different countries in the references and in Table VIII .
The only way of obtaining uninfected animals is to avoid the perinatal infection of kids, abolish all contact with the dam, supply colostrum and milk free from CAE virus and rear kids away from infected goats. CAE virus in colostrum and milk can be destroyed by heating to 56°C for 1 h (147), to 72°C for 15 sec (183), or 57°C for 10 min, followed by a holding period in temperature-controlled bottles for an hour. A common practice is to feed newborn kids on colostrum which has been heated to 56°C for 1 h and then, from the third day, cow's milk reconstituted from milk powder. Excellent results can be obtained if the kids are separated from the dam immediately after birth to avoid licking and suckling and if they are kept away from infected goats (147, 183) . If the latter precaution is not taken, the results are less satisfactory (199) . Any antibodies to CAE virus acquired by kids are eliminated within 2 to 3 months. It must be pointed out that colostrum and milk from a seronegative goat could still contain CAE virus capable of transmitting the infection (147).
In applying these findings, many countries have set up schemes for certifying herds and for eradicating infection (see Table VIII ) (182, 162, 185) , usually based on voluntary participation by goat breeders supported by the veterinary service.
All these schemes envisage accreditation of herds without an official eradication scheme for infected herds. In each scheme there are three stages: -Stage 1: definition of the disease status of a herd; -Stage 2: establishment of the presence or absence of infection in a herd by repeated testing, leading to certification of freedom from CAE; -Stage 3: definition of the way in which this status can be maintained.
The first stage is accomplished by a serological survey of a significant proportion of the goats in the herd (aged over 12 months in France and over 9 months in the UK), or of all weaned goats (New Zealand). In France and the UK a second test of all goats is required to reach stage 2, provided that all the tests are negative.
Stage 2 consists of another serological testing of the entire herd, done twice at an interval of 6 to 9 months (UK), or only once (New Zealand). If the results are entirely negative, the herd is certified as being officially free from CAE infection.
Maintenance of this qualification is assured by annual serological testing of at least 25% of the females of the herd (France), or of all animals (France, New Zealand), or by testing at intervals of 18 to 24 months (UK).
The results achieved have been satisfactory and provide hope for controlling the disease without resorting to eradication measures which would be difficult to sustain economically.
*
* *
Following the presentation and discussion of this report, Resolution No. XV was adopted at the 58th General Session of the OIE in May 1990.
